Clinical trial
Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes…
NCT00314964 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00314964 |
|---|---|
| Title | Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study Evaluating PD-0299685 for Treatment of Vasomotor Symptoms Associated With Menopause |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hot Flashes |
| Intervention type | Drug |
| Interventions | PD-0299685 |
| Enrollment | 527 |
| Start date | Aug 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Apr 17, 2006 |
| Last update posted | Mar 16, 2011 |
| Countries | Australia, Canada, France, South Africa, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: